Skip to content

IMAGING COGNITIVE METACONTROL STATES DURING MEDITATION AND CREATIVE THINKING

IMAGING COGNITIVE METACONTROL STATES DURING MEDITATION AND CREATIVE THINKING - IMSTA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55268
Enrollment
60
Registered
2020-08-24
Start date
2021-12-14
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geen stoornissen: cognitief psychologisch onderzoek in gezonde deelnemers N/A: Healthy volunteers

Interventions

None listed

Sponsors

Universiteit Leiden
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Dutch native speaker - Between 18 and 55 years of age; - Right handed - Self-reported normal (or corrected to normal) vision in both eyes. - Thorough experience with mediation, familiar with the FAM (e.g. Deep Meditiation, Vipassana & Zen) and OMM (e.g. Mindfulness) techniques These criteria will be assessed by a self-report questionnaire administered during screening, which the participants will sign to confirm the answers.

Exclusion criteria

Exclusion criteria: - Non-native speaker of Dutch. - Left handed. - No / not enough experience with meditation. - Significant history of head trauma . - Hypertension. - Use of anti-depressants or psychotropic medication (e.g. benzodiazepines) - Possible pregnancy (in adult females). - In general, participants should not report any history of psychiatric problems and neurological disorders, and should not currently use any medication that could influence cognition and blood flow in the brain (e.g. benzodiazepines, anti-depressants, according to standard fMRI protocol when testing healthy participants). - MRI contra-indications, including metal implants and claustrophobia, as assessed with standard LIBC MRI contra-indication checklist. These criteria will be assessed by a self-report questionnaire administered during screening, which the participants will sign to confirm the answers.

Design outcomes

Primary

MeasureTime frame
Resting state functional brain connectivity

Secondary

MeasureTime frame
We will additionally include mood measurements in the GLM analyses of the fMRI data, as possible confounders of the behavioural measures. Psychohysiological measures: heart rate, respiration rate will also be included in the analyses of the fMRI signal as possible confounders of the BOLD signal. Behavioral data of creativity tasks and fMRI neural signals will be associated to study possible predictive relationships. Moreover, structural morphometry / signal intensity and connectivity will be taken into account to explain possible effects seen in functional connectivity when comparing the different cognitive states.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)